Literature DB >> 24993285

BDNF SNPs are implicated in comorbid alcohol dependence in schizophrenia but not in alcohol-dependent patients without schizophrenia.

Sern-Yih Cheah1, Bruce R Lawford2, Ross McD Young1, Jason P Connor3, C Phillip Morris1, Joanne Voisey4.   

Abstract

AIMS: The functional BDNF single nucleotide polymorphism (SNP) rs6265 has been associated with many disorders including schizophrenia and alcohol dependence. However, studies have been inconsistent, reporting both positive and negative associations. Comorbid alcohol dependence has a high prevalence in schizophrenia so we investigated the role of rs6265 in alcohol dependence in Australian populations of schizophrenia and alcohol-dependent patients.
METHODS: Two BDNF SNPs rs6265 and a nearby SNP rs7103411 were genotyped in a total of 848 individuals. These included a schizophrenia group (n = 157) and a second schizophrenia replication group (n = 235), an alcohol-dependent group (n = 231) that had no schizophrenia diagnosis and a group of healthy controls (n = 225).
RESULTS: Allelic association between rs7103411 and comorbid alcohol dependence was identified (P = 0.044) in the primary schizophrenia sample. In the replication study, we were able to detect allelic associations between both BDNF SNPs and comorbid alcohol dependence (rs6265, P = 0.006; rs7103411, P = 0.014). Moreover, we detected association between both SNPs and risk-taking behaviour after drinking (rs6265, P = 0.005; rs7103411, P = 0.009) and we detected strong association between both SNPs and alcohol dependence in males (rs6265, P = 0.009; rs7103411, P = 0.013) while females showed association with multiple behavioural measures reflecting repetitive alcohol consumption. Haplotype analysis revealed the rs6265-rs7103411 A/C haplotype is associated with comorbid alcohol dependence (P = 0.002). When these SNPs were tested in the non-schizophrenia alcohol-dependent group we were unable to detect association.
CONCLUSION: We conclude that these BDNF SNPs play a role in development of comorbid alcohol dependence in schizophrenia while our data do not indicate that they play a role in alcohol-dependent patients who do not have schizophrenia.
© The Author 2014. Medical Council on Alcohol and Oxford University Press. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24993285     DOI: 10.1093/alcalc/agu040

Source DB:  PubMed          Journal:  Alcohol Alcohol        ISSN: 0735-0414            Impact factor:   2.826


  8 in total

1.  Association of BDNF Polymorphisms with the Risk of Epilepsy: a Multicenter Study.

Authors:  Hidayati Mohd Sha'ari; Batoul Sadat Haerian; Larry Baum; Hui Jan Tan; Mohd Hanip Rafia; Patrick Kwan; Stacey S Cherny; Pak Chung Sham; Hongsheng Gui; Azman Ali Raymond; Kheng Seang Lim; Zahurin Mohamed
Journal:  Mol Neurobiol       Date:  2015-04-16       Impact factor: 5.590

Review 2.  The link between schizophrenia and substance use disorder: A unifying hypothesis.

Authors:  Jibran Y Khokhar; Lucas L Dwiel; Angela M Henricks; Wilder T Doucette; Alan I Green
Journal:  Schizophr Res       Date:  2017-04-14       Impact factor: 4.939

3.  SorCS2 is required for BDNF-dependent plasticity in the hippocampus.

Authors:  S Glerup; U Bolcho; S Mølgaard; S Bøggild; C B Vaegter; A H Smith; J L Nieto-Gonzalez; P L Ovesen; L F Pedersen; A N Fjorback; M Kjolby; H Login; M M Holm; O M Andersen; J R Nyengaard; T E Willnow; K Jensen; A Nykjaer
Journal:  Mol Psychiatry       Date:  2016-07-26       Impact factor: 15.992

4.  Transmissibility and familiality of NEO personality dimensions in a sample of Korean families with schizophrenia.

Authors:  Soo Yeon Kim; Byung Dae Lee; Je Min Park; Young Min Lee; Eunsoo Moon; Hee Jeong Jeong; Young In Chung
Journal:  Medicine (Baltimore)       Date:  2018-02       Impact factor: 1.817

5.  Association of Plasma Pro-Brain-Derived Neurotrophic Factor (proBDNF)/Mature Brain-Derived Neurotrophic Factor (mBDNF) Levels with BDNF Gene Val66Met Polymorphism in Alcohol Dependence.

Authors:  Min Mo; Xi-Yue Fu; Xu-Lan Zhang; Shao-Chuan Zhang; Hai-Qing Zhang; Li Wu; Jia-Lei Li; Li Zhou
Journal:  Med Sci Monit       Date:  2021-08-20

6.  Protocol for Characterization of Addiction and Dual Disorders: Effectiveness of Coadjuvant Chronotherapy in Patients with Partial Response.

Authors:  Ana Adan; José Francisco Navarro
Journal:  J Clin Med       Date:  2022-03-26       Impact factor: 4.241

7.  NRSF and BDNF polymorphisms as biomarkers of cognitive dysfunction in adults with newly diagnosed epilepsy.

Authors:  Alix Warburton; Fabio Miyajima; Kanvel Shazadi; Joanne Crossley; Michael R Johnson; Anthony G Marson; Gus A Baker; John P Quinn; Graeme J Sills
Journal:  Epilepsy Behav       Date:  2015-12-17       Impact factor: 2.937

Review 8.  Alcohol Use Disorder and Schizophrenia or Schizoaffective Disorder.

Authors:  Luke Archibald; Mary F Brunette; Diana J Wallin; Alan I Green
Journal:  Alcohol Res       Date:  2019-12-20
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.